![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Nicholas Borcherding, Ajaykumar Vishwakarma, Andrew P. Voigt, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 222
Nicholas Borcherding, Ajaykumar Vishwakarma, Andrew P. Voigt, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 222
Showing 1-25 of 222 citing articles:
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
Yuping Zhang, Sathiya Pandi Narayanan, Rahul Mannan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 222
Yuping Zhang, Sathiya Pandi Narayanan, Rahul Mannan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 222
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 353-362
Open Access | Times Cited: 192
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 353-362
Open Access | Times Cited: 192
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Chloé B. Steen, Bogdan Luca, Mohammad Shahrokh Esfahani, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1422-1437.e10
Open Access | Times Cited: 173
Chloé B. Steen, Bogdan Luca, Mohammad Shahrokh Esfahani, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1422-1437.e10
Open Access | Times Cited: 173
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1497-1518.e11
Open Access | Times Cited: 172
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1497-1518.e11
Open Access | Times Cited: 172
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer
Ruoyan Li, John R. Ferdinand, Kevin W. Loudon, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1583-1599.e10
Open Access | Times Cited: 97
Ruoyan Li, John R. Ferdinand, Kevin W. Loudon, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1583-1599.e10
Open Access | Times Cited: 97
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 139-163.e17
Open Access | Times Cited: 97
Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 139-163.e17
Open Access | Times Cited: 97
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies
Emily R. Kansler, Saïda Dadi, Chirag Krishna, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 904-915
Open Access | Times Cited: 65
Emily R. Kansler, Saïda Dadi, Chirag Krishna, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 904-915
Open Access | Times Cited: 65
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses
Mingyu He, Kate Roussak, Feiyang Ma, et al.
Science (2023) Vol. 379, Iss. 6633
Open Access | Times Cited: 52
Mingyu He, Kate Roussak, Feiyang Ma, et al.
Science (2023) Vol. 379, Iss. 6633
Open Access | Times Cited: 52
Clear Cell Renal Cell Carcinoma: From Biology to Treatment
Adam M. Kase, Daniel J. George, Sundhar Ramalingam
Cancers (2023) Vol. 15, Iss. 3, pp. 665-665
Open Access | Times Cited: 40
Adam M. Kase, Daniel J. George, Sundhar Ramalingam
Cancers (2023) Vol. 15, Iss. 3, pp. 665-665
Open Access | Times Cited: 40
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer
Sudhir B. Malla, Ryan M. Byrne, Maxime W. Lafarge, et al.
Nature Genetics (2024) Vol. 56, Iss. 3, pp. 458-472
Open Access | Times Cited: 19
Sudhir B. Malla, Ryan M. Byrne, Maxime W. Lafarge, et al.
Nature Genetics (2024) Vol. 56, Iss. 3, pp. 458-472
Open Access | Times Cited: 19
Autoreactive T cells target peripheral nerves in Guillain–Barré syndrome
Lenka Súkeníková, Anna Mallone, Bettina Schreiner, et al.
Nature (2024) Vol. 626, Iss. 7997, pp. 160-168
Open Access | Times Cited: 18
Lenka Súkeníková, Anna Mallone, Bettina Schreiner, et al.
Nature (2024) Vol. 626, Iss. 7997, pp. 160-168
Open Access | Times Cited: 18
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy
Jeremy Baldwin, Christoph Heuser, Tanmoy Saha, et al.
Cell (2024) Vol. 187, Iss. 23, pp. 6614-6630.e21
Open Access | Times Cited: 15
Jeremy Baldwin, Christoph Heuser, Tanmoy Saha, et al.
Cell (2024) Vol. 187, Iss. 23, pp. 6614-6630.e21
Open Access | Times Cited: 15
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer
Jad I. Belle, D. Sen, John Baer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1324-1355
Closed Access | Times Cited: 14
Jad I. Belle, D. Sen, John Baer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1324-1355
Closed Access | Times Cited: 14
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis
Simon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 682-692
Open Access | Times Cited: 13
Simon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 682-692
Open Access | Times Cited: 13
Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation
Gerdien Mijnheer, Lisanne Lutter, Michal Mokrý, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 69
Gerdien Mijnheer, Lisanne Lutter, Michal Mokrý, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 69
CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells
Myung‐Chul Kim, Nicholas Borcherding, Kawther Khalid Ahmed, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Myung‐Chul Kim, Nicholas Borcherding, Kawther Khalid Ahmed, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility
Mandy Meijer, Eneritz Agirre, Mukund Kabbe, et al.
Neuron (2022) Vol. 110, Iss. 7, pp. 1193-1210.e13
Open Access | Times Cited: 60
Mandy Meijer, Eneritz Agirre, Mukund Kabbe, et al.
Neuron (2022) Vol. 110, Iss. 7, pp. 1193-1210.e13
Open Access | Times Cited: 60
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 57
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 57
Mapping the human kidney using single-cell genomics
Felix Schreibing, Rafael Kramann
Nature Reviews Nephrology (2022) Vol. 18, Iss. 6, pp. 347-360
Closed Access | Times Cited: 53
Felix Schreibing, Rafael Kramann
Nature Reviews Nephrology (2022) Vol. 18, Iss. 6, pp. 347-360
Closed Access | Times Cited: 53
Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review
Lu Zhang, Wen Zhang, Ziye Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 43
Lu Zhang, Wen Zhang, Ziye Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 43
Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing
Yue Shi, Qi Zhang, Hai Bi, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Yue Shi, Qi Zhang, Hai Bi, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity
Xiuting Liu, Graham D. Hogg, Chong Zuo, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1073-1090.e12
Open Access | Times Cited: 35
Xiuting Liu, Graham D. Hogg, Chong Zuo, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1073-1090.e12
Open Access | Times Cited: 35
Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework
Jinsong Liu, Yanjia Shi, Yuxin Zhang
The EPMA Journal (2023) Vol. 14, Iss. 2, pp. 275-305
Open Access | Times Cited: 32
Jinsong Liu, Yanjia Shi, Yuxin Zhang
The EPMA Journal (2023) Vol. 14, Iss. 2, pp. 275-305
Open Access | Times Cited: 32
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer
Brett H. Herzog, John Baer, Nicholas Borcherding, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 699
Closed Access | Times Cited: 28
Brett H. Herzog, John Baer, Nicholas Borcherding, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 699
Closed Access | Times Cited: 28